Other analysts have also recently issued reports about the company. J P Morgan Chase & Co upped their target price on Victrex from GBX 2,150 ($28.94) to GBX 2,250 ($30.28) and gave the company a neutral rating in a report on Wednesday. Jefferies Group upped their target price on Victrex from GBX 2,050 ($27.59) to GBX 2,268 ($30.52) and gave the company a hold rating in a report on Tuesday, September 5th. Peel Hunt upped their target price on Victrex from GBX 2,100 ($28.26) to GBX 2,300 ($30.96) and gave the company an add rating in a report on Tuesday, September 5th. Deutsche Bank increased their price target on Victrex from GBX 1,850 ($24.90) to GBX 2,050 ($27.59) and gave the stock a hold rating in a report on Tuesday, September 5th. Finally, Liberum Capital restated a buy rating and set a GBX 2,440 ($32.84) price target on shares of Victrex in a report on Tuesday. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of Hold and an average target price of GBX 2,248.91 ($30.27).
Shares of Victrex (LON VCT) traded up GBX 141.33 ($1.90) during mid-day trading on Tuesday, reaching GBX 2,532.33 ($34.08). The company had a trading volume of 497,875 shares, compared to its average volume of 243,192. Victrex has a 1-year low of GBX 1,720 ($23.15) and a 1-year high of GBX 2,607 ($35.09).
Victrex Company Profile
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.